Concerns Around CVS Health (CVS) Accelerated PBM Losses Likely Overblown - Cantor Fitzgerald
Tweet Send to a Friend
Cantor Fitzgerald analyst Steven Halper reiterated an Overweight rating and $80.00 price target on CVS Health (NYSE: CVS) saying concerns ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
